Genscript Biotech Corp

Common Name
Genscript Biotech
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
5,568
Ticker
1548
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
GenScript Biotech Corporation is a prominent entity within the biotechnology sector, specializing in the provision of life sciences research services and products globally. The company serves as a vit...

Financial Statements of Genscript Biotech

Below are the financial statements of Genscript Biotech, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

All figures in millions of USD20242023
Non-current assets
Property, plant and equipment
518a
608.11a
Advance payments for property, plant and equipment, net
7.22a
22.22a
Investment properties
4.85a
5.44a
Right-of-use assets
77.62a
120.62a
Goodwill
1.34a
1.36a
Other intangible assets
13.04a
18.65a
Investments in associates
3,667.73a
15.29a
Financial assets at fair value through profit or loss
88.64a
31.87a
Deferred tax assets
27.74a
16.51a
Time deposits
33.39a
38.25a
Other non-current assets
3.74a
155.89a
Total non-current assets
4,443.29a
1,034.19a
Current assets
Inventories
31.1a
53.35a
Contract costs
19.35a
17.88a
Trade and bills receivables
116.29a
217.44a
Prepayments, other receivables and other assets
29.14a
103.32a
Financial assets at fair value through profit or loss
224.87a
105.65a
Restricted cash
17.92a
33.07a
Time deposits
264.32a
376a
Cash and cash equivalents
131.99a
1,446.4a
Total current assets
834.98a
2,353.11a
Current liabilities
Trade and bills payables
29.84a
39.96a
Other payables and accruals
125.53a
273.41a
Interest-bearing loans and other borrowings
88.75a
57.01a
Lease liabilities
7.52a
8.87a
Tax payable
9.39a
18.13a
Contract liabilities
46.21a
97.44a
Financial liabilities at fair value through profit or loss
0.11a
0a
Total current liabilities
307.34a
494.81a
Net current assets
527.64a
1,858.3a
Total assets less current liabilities
4,970.93a
2,892.49a
Non-current liabilities
Interest-bearing loans and other borrowings
17.31a
287.21a
Lease liabilities
56.99a
63.91a
Contract liabilities
0a
47.96a
Deferred tax liabilities
5.84a
5.62a
Financial liabilities at fair value through profit or loss
473.73a
350.15a
Financial liabilities measured at amortised cost
79.44a
75.36a
Other non-current liabilities
14.26a
17.93a
Total non-current liabilities
647.57a
848.14a
Net assets
4,323.36a
2,044.35a
Equity
Share capital
2.14a
2.12a
Treasury shares
-6.09a
-9.45a
Reserves
4,325.12a
1,398.4a
Equity attributable to owners of the parent
4,321.17a
1,391.08a
Non-controlling interests
2.19a
653.28a
Total equity
4,323.36a
2,044.35a

Verified Sources Behind Genscript Biotech’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Genscript Biotech’s data sources below and access millions more through our Disclosure Search.

a. Genscript Biotech's Annual Report 2024
Trace every data point back to Genscript Biotech’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?